Related Experiment Video
Updated: Jul 29, 2026

19:15
Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
90.5K
The Neuro-sensory Motor Developmental Assessment Part 1: Development and Administration of the Test
The Australian Journal of Physiotherapy
|July 16, 2014
Summary
The Neuro-sensory Motor Developmental Assessment (NSMDA) offers a progressive tool for evaluating infant and child development. This study validates the NSMDA’s predictability in assessing developmental status in preterm infants up to 24 months.
Area of Science:
- Pediatric developmental assessment
- Neurodevelopmental disorders
- Infant motor skills evaluation
Background:
- The Neuro-sensory Motor Developmental Assessment (NSMDA) was created to address the need for a progressive developmental evaluation tool for infants and children.
- Preterm infants often exhibit developmental delays and require specialized assessment tools.
Purpose of the Study:
- To describe the development and administration of the NSMDA.
- To establish the validity and predictability of the NSMDA in preterm infants.
- To classify developmental status (normal, suspect, abnormal) in preterm infants.
Main Methods:
- A cohort of 148 preterm infants was assessed using the NSMDA at 1, 4, 8, 12, and 24 months adjusted age.
- Longitudinal and cross-correlations of NSMDA scores were analyzed.
- Scores were correlated with 24-month outcome scores.
Main Results:
- Longitudinal and cross-correlations of NSMDA scores demonstrated high significance over the first two years of testing.
- The NSMDA effectively classified subjects into normal, suspect, or abnormal developmental status categories.
- NSMDA scores showed significant correlation with 24-month outcome scores.
Conclusions:
- The NSMDA is a valid and predictable tool for assessing neuro-sensory motor development in preterm infants.
- The assessment provides a reliable method for tracking developmental trajectories from infancy through early childhood.
- The NSMDA supports early identification and intervention for infants at risk for developmental abnormalities.

